Pinto, N. R., Hibbitts, E., Kreissman, S. G., Granger, M. P., Irwin, M., Bagatell, R., … DuBois, S. G. (2018). Predictors of differential response to induction chemotherapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG). In Journal of Clinical Oncology (Vol. 36, pp. 10532–10532). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.10532

Pinto, Navin R., Emily Hibbitts, Susan G. Kreissman, Meaghan P. Granger, Meredith Irwin, Rochelle Bagatell, Wendy B. London, et al. “Predictors of differential response to induction chemotherapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG).” In Journal of Clinical Oncology, 36:10532–10532. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.10532.

Pinto NR, Hibbitts E, Kreissman SG, Granger MP, Irwin M, Bagatell R, et al. Predictors of differential response to induction chemotherapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG). In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 10532–10532.

Pinto, Navin R., et al. “Predictors of differential response to induction chemotherapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG).” Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. 10532–10532. Crossref, doi:10.1200/jco.2018.36.15_suppl.10532.

Pinto NR, Hibbitts E, Kreissman SG, Granger MP, Irwin M, Bagatell R, London WB, Greengard EG, Naranjo A, Park JR, DuBois SG. Predictors of differential response to induction chemotherapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 10532–10532.